BAY 60-6583 Enhances the Antitumor Function of Chimeric Antigen Receptor-Modified T Cells Independent of the Adenosine A2b Receptor

Galunisertib enhances chimeric antigen receptor-modified T cell function

(2020) Zhixiong Wang et al.   EUROPEAN JOURNAL OF HISTOCHEMISTRY

Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4+ T Cell Pathogenicity and Suppresses Autoimmunity

(2019) Stefano Angiari et al.   Cell Metabolism

A2B Adenosine Receptor and Cancer

(2019) Zhan-Guo Gao et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T Cells

(2018) Bian Hu et al.   HUMAN GENE THERAPY

The Circadian Clock Controls Immune Checkpoint Pathway in Sepsis

(2018) Wenjun Deng et al.   Cell Reports

ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival

(2018) SM Gilbert et al.   ONCOGENE

Targeting Adenosine Receptor Signaling in Cancer Immunotherapy

(2018) Kevin Sek et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer

(2017) Mohammad H. Kazemi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

(2017) Paul A. Beavis et al.   JOURNAL OF CLINICAL INVESTIGATION

Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors

(2017) Eva M. Palsson-McDermott et al.   Frontiers in Immunology

Chimeric antigen receptors: driving immunology towards synthetic biology

(2016) Michel Sadelain   CURRENT OPINION IN IMMUNOLOGY

Immunosuppressive activities of adenosine in cancer

(2016) Bertrand Allard et al.   CURRENT OPINION IN PHARMACOLOGY

The Integrin LFA-1 Controls T Follicular Helper Cell Generation and Maintenance

(2016) Alexandre P. Meli et al.   IMMUNITY

Chimeric antigen receptor T-cell therapy for solid tumors

(2016) Kheng Newick et al.   Molecular Therapy-Oncolytics

The I-TASSER Suite: protein structure and function prediction

(2015) Jianyi Yang et al.   NATURE METHODS

Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57

(2015) Xuekai Zhu et al.   Oncotarget

The actin-bundling protein L-plastin supports T-cell motility and activation

(2014) Sharon Celeste Morley   IMMUNOLOGICAL REVIEWS

Adenosine A2B receptor antagonist PSB603 suppresses tumor growth and metastasis by inhibiting induction of regulatory T cells

(2014) Wakako Kaji et al.   JOURNAL OF TOXICOLOGICAL SCIENCES

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

(2013) G. Madhavi Sastry et al.   JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms

(2013) Anke C. Schiedel et al.   Purinergic Signalling

A2B adenosine receptor blockade inhibits growth of prostate cancer cells

(2013) Qiang Wei et al.   Purinergic Signalling

Toward Protein Biomarkers for Allergy: CD4+ T Cell Proteomics in Allergic and Nonallergic Subjects Sampled in and out of Pollen Season

(2011) Martin Blüggel et al.   JOURNAL OF PROTEOME RESEARCH

Thymus hormones as prospective anti-inflammatory agents

(2010) Sergey M Lunin et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

The promise and potential pitfalls of chimeric antigen receptors

(2009) Michel Sadelain et al.   CURRENT OPINION IN IMMUNOLOGY